Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia

1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia

US Patent 8933083 · Granted Jan 13, 2015

Estimated economic value: $24,903,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscarinic acetylcholine M1 receptor antagonists2025
Vasopressin receptor antagonists and products and methods related thereto2024
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as2024
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as2024
Cannabinoid receptor modulators2024
Cannabinoid receptor modulators2024
Muscarinic acetylcholine M1 receptor antagonists2024
Kappa opioid receptor antagonists and products and methods related thereto2024
Vasopressin receptor antagonists and products and methods related thereto2024
Quinazolinone compounds and related compounds2023
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023